Resmed Inc
RMD.N- Latest Trade
- trading higher214.93USD
- 0.16
- 0.07%
- As of Jun 9 2023. Values delayed up to 15 minutes
- Today's Range
- 212.62 - 215.09
- 52 Week Range
- 194.56 - 247.53
- Previous Close
- 214.77
- Open
- 213.89
- Volume
- 182,484.00
- 3 Month Average Trading Volume
- 12.61
- Shares Out (Mil)
- 146.93
- Market Cap
- 31,556.30
- Forward P/E
- 32.95
- Dividend Yield
- 0.82
Key Statistics
2.20 mean rating - 15 analysts
- P/E Excl. Extra Items (TTM)
- 36.65
- Price To Sales (TTM)
- 7.86
- Price To Book (Quarterly)
- 8.02
- Price To Cash Flow (Per Share TTM)
- 30.98
- Total Debt/Total Equity (Quarterly)
- 40.33
- Long Term Debt/Equity (Quarterly)
- 40.08
- Return On Investment (TTM)
- 16.94
- Return On Equity (TTM)
- 14.85
2021 (millions USD)
About Resmed Inc (RMD.N)
Company Information
ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. It also offers software solutions for a variety of out-of-hospital care providers. The Company has two segments: Sleep and Respiratory Care and the Software-as-a-Service. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices and cloud-based software informatics solutions.
Address
9001 Spectrum Center BlvdSAN DIEGO, CA
92123-1438
United States
Industry
Medical Equipment & Supplies
Executive Leadership
- Michael J. Farrell
- Chairman of the Board
- Peter C. Farrell
- Chairman Emeritus
- Robert Andrew Douglas
- President, Chief Operating Officer
- Brett A. Sandercock
- Chief Financial Officer
- Lucile Blaise
- President - Sleep and Respiratory Care business
- Bobby Ghoshal
- President - SaaS Business
- Justin M. W. Leong
- President, Asia and Latin America
- David Brian Pendarvis
- Chief Administrative Officer, Global General Counsel, Secretary
- Dawn Haake
- Chief Quality Officer
- Amy Wakeham
- Chief Communications and Investor Relations Officer
- Ronald R. Taylor
- Lead Independent Director
- Carol J. Burt
- Independent Director
- Jan De Witte
- Independent Director
- Karen Drexler
- Independent Director
- Harjit Gill
- Independent Director
- John B. Hernandez
- Independent Director
- Richard Sulpizio
- Independent Director
- Desney Tan
- Independent Director
Latest News
- MarketsGoodyear, Cornerstone Building Brands, Axcella Health, big tech
Wall Street futures slid on Monday, as rising geopolitical tensions between Russia and the West posed a double whammy for investors already worried about aggressive policy tightening by the Federal Reserve to combat surging inflation.
- MarketsBig banks, Splunk, BioDelivery, Amesite
Wall Street futures slid on Monday, as rising geopolitical tensions between Russia and the West posed a double whammy for investors already worried about aggressive policy tightening by the Federal Reserve to combat surging inflation.
Financials
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,964.70 | 0.06% |
| Copper | 726.75 | 0.24% |
| Brent Crude Oil | 76.25 | 0.38% |
| CBOT Soybeans | 1,369.00 | 0.42% |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,293.93 | 0.62% |
| Euro STOXX 50 | 4,299.79 | 0.05% |
| FTSE 100 | 7,597.83 | 0.03% |
| Nikkei 225 | 32,265.17 | 1.97% |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes